Cargando…

Artemether Combined with shRNA Interference of Vascular Cell Adhesion Molecule-1 Significantly Inhibited the Malignant Biological Behavior of Human Glioma Cells

Artemether is the derivative extracted from Chinese traditional herb and originally used for malaria. Artemether also has potential therapeutic effects against tumors. Vascular cell adhesion molecule-1 (VCAM-1) is an important cell surface adhesion molecule associated with malignancy of gliomas. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ying-Bin, Hu, Yi, Li, Zhen, Wang, Ping, Xue, Yi-Xue, Yao, Yi-Long, Yu, Bo, Liu, Yun-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623969/ https://www.ncbi.nlm.nih.gov/pubmed/23593320 http://dx.doi.org/10.1371/journal.pone.0060834

Ejemplares similares

A Simple and Robust Vector-Based shRNA Expression System Used for RNA Interference
por: Wang, Xue-jun, et al.
Publicado: (2013)

Systems analysis of quantitative shRNA-library screens identifies regulators of cell adhesion
por: Huang, XiaoDong, et al.
Publicado: (2008)

Lentivirus‐mediated shRNA interference of ghrelin receptor blocks proliferation in the colorectal cancer cells
por: Liu, An, et al.
Publicado: (2016)

Significant Interference with Porcine Epidemic Diarrhea Virus Pandemic and Classical Strain Replication in Small-Intestine Epithelial Cells Using an shRNA Expression Vector
por: Shi, Da, et al.
Publicado: (2019)

Lentivirus-mediated shRNA interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells
por: Fu, Yanxia, et al.
Publicado: (2015)

The effects of stem length and core placement on shRNA activity
por: Mcintyre, Glen J, et al.
Publicado: (2011)

Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010)

ShRNA-mediated silencing of hTERT promote apoptosis and senescence in human ovarian cancer cells
por: Su, Chen, et al.
Publicado: (2019)

Specific interference shRNA-expressing plasmids inhibit Hantaan virus infection in vitro and in vivo
por: Liu, Yuan-yuan, et al.
Publicado: (2016)

Optimized PCR Conditions and Increased shRNA Fold Representation Improve Reproducibility of Pooled shRNA Screens
por: Strezoska, Žaklina, et al.
Publicado: (2012)

Effect of CDCA5 on Proliferation and Metastasis of Triple Negative Breast Cancer Cells under shRNA Interference Technology
por: Li, Yilin, et al.
Publicado: (2022)

Periodic-shRNA molecules are capable of gene silencing, cytotoxicity and innate immune activation in cancer cells
por: Shopsowitz, Kevin E., et al.
Publicado: (2016)

High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing
por: Sims, David, et al.
Publicado: (2011)

Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response
por: Kranjc Brezar, Simona, et al.
Publicado: (2020)

Silencing of ENO1 by shRNA Inhibits the Proliferation of Gastric Cancer Cells
por: Qiao, Hui, et al.
Publicado: (2018)

Lentivirus-mediated shRNA targeting MUTYH inhibits malignant phenotypes of bladder cancer SW780 cells
por: Gao, Qunjun, et al.
Publicado: (2018)

shRNA target prediction informed by comprehensive enquiry (SPICE): a supporting system for high-throughput screening of shRNA library
por: Kamatuka, Kenta, et al.
Publicado: (2016)

Silencing NEDD9 by lentivirus-delivered shRNA inhibits the growth of BxPC-3 cells in vitro and in vivo
por: Wu, Tielong, et al.
Publicado: (2019)

Knockdown of CREB3/Luman by shRNA in Mouse Granulosa Cells Results in Decreased Estradiol and Progesterone Synthesis and Promotes Cell Proliferation
por: Zhao, Fan, et al.
Publicado: (2016)

Biologically responsive carrier-mediated anti-angiogenesis shRNA delivery for tumor treatment
por: Che, Junyi, et al.
Publicado: (2016)

Improved siRNA/shRNA Functionality by Mismatched Duplex
por: Wu, Haoquan, et al.
Publicado: (2011)

Multiple shRNA combinations for near-complete coverage of all HIV-1 strains
por: Mcintyre, Glen J, et al.
Publicado: (2011)

CADASIL mutations and shRNA silencing of NOTCH3 affect actin organization in cultured vascular smooth muscle cells
por: Tikka, Saara, et al.
Publicado: (2012)

Chemosensitizing effect of shRNA-mediated ERCC1 silencing on a Xuanwei lung adenocarcinoma cell line and its clinical significance
por: Wang, Weiwei, et al.
Publicado: (2017)

AAV Delivery of shRNA Against TRPC6 in Mouse Hippocampus Impairs Cognitive Function
por: Xie, Ruxin, et al.
Publicado: (2021)

Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012)

Effect of shRNA Mediated Silencing of YB-1 Protein on the Expression of Matrix Collagenases in Malignant Melanoma Cell In Vitro
por: Ibrahim, Wisam Nabeel, et al.
Publicado: (2018)

Evaluation of the Elements of Short Hairpin RNAs in Developing shRNA-Containing CAR T Cells
por: Urak, Ryan, et al.
Publicado: (2023)

Delivery of Therapeutic AGT shRNA by PEG-Bu for Hypertension Therapy
por: Wang, Yu-Qiang, et al.
Publicado: (2013)

Intron-specific shRNA-mediated downregulation of survivin and promotion of apoptosis in HeLa cells
por: Wang, Yue-Li, et al.
Publicado: (2017)

Study of the UTMD-Based Delivery System to Induce Cervical Cancer Cell Apoptosis and Inhibit Proliferation with shRNA targeting Survivin
por: Chen, Zhi-Yi, et al.
Publicado: (2013)

Optimization and characterization of tRNA-shRNA expression constructs
por: Scherer, Lisa J., et al.
Publicado: (2007)

Design and cloning strategies for constructing shRNA expression vectors
por: McIntyre, Glen J, et al.
Publicado: (2006)

Optimization of Duplex Stability and Terminal Asymmetry for shRNA Design
por: Matveeva, Olga V., et al.
Publicado: (2010)

Energy profile and secondary structure impact shRNA efficacy
por: Zhou, Hong, et al.
Publicado: (2009)

Production of Transgenic Calves Expressing an shRNA Targeting Myostatin
por: Tessanne, K, et al.
Publicado: (2012)

Using shRNA experiments to validate gene regulatory networks
por: Olsen, Catharina, et al.
Publicado: (2015)

Silencing Human Rb2/p130 with shRNA
por: Leucci, Eleonora, et al.
Publicado: (2007)

Stable expression of shRNA for the control of recombinant adenovirus replication
por: Lana, M.V.G., et al.
Publicado: (2023)

An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors()
por: Patel, Ami V., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_29f63q4pvojauft905c07q203i